Filtered By:
Source: Yonsei Medical Journal
Condition: Hemorrhagic Stroke
This page shows you your search results in order of date. This is page number 2.
Order by Relevance | Date
Total 48 results found since Jan 2013.
Didymin Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the PPAR Signaling Pathway
CONCLUSION: Didymin protected neuron cells against IR injury in vitro and in vivo by activation of the PPAR pathway. Didymin may be a candidate drug for IR treatment.PMID:36168249 | PMC:PMC9520049 | DOI:10.3349/ymj.2022.0040
Source: Yonsei Medical Journal - September 28, 2022 Category: Universities & Medical Training Authors: Qiang Li Hongting Zhang Xiumei Liu Source Type: research
Delays in Intracerebral Hemorrhage Management Is Associated with Hematoma Expansion and Worse Outcomes: Changes in COVID-19 Era
CONCLUSION: During the COVID-19 era, delays in management of ICH was associated with hematoma expansion and worse outcomes.PMID:34558870 | DOI:10.3349/ymj.2021.62.10.911
Source: Yonsei Medical Journal - September 24, 2021 Category: Universities & Medical Training Authors: Hyun Jin Han Keun Young Park Junhyung Kim Woosung Lee Yun Ho Lee Chang Ki Jang Kwang-Chun Cho Sang Kyu Park Joonho Chung Young Sub Kwon Yong Bae Kim Jae Whan Lee So Yeon Kim Source Type: research
